Nasal carriage of methicillin-resistant Staphylococcus aureus in vascular surgery

Annals of Vascular Surgery

Volumn 20, Issue 6, 2006, Pages 767-772

  Morange Saussier, Virginie ^a,c   Giraudeau, Bruno ^b   Van Der Mee, Nathalie ^a   Lermusiaux, Patrick ^a   Quentin, Roland ^a,b  

^a SERVICE DE DERMATOLOGIE   (France)

^b UNIVERSITÉ DE TOURS   (France)

^c CHU BRETONNEAU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIUM IDENTIFICATION; CASE CONTROL STUDY; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; HEALTH CARE FACILITY; HOSPITAL ADMISSION; HOSPITAL DEPARTMENT; HUMAN; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRIORITY JOURNAL; SCREENING TEST; SURGICAL PATIENT; VASCULAR SURGERY;

EID: 33845885110     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10016-006-9088-x     Document Type: Conference Paper

References (20)

1. Anonymous, Ministère de l'emploi et de la solidarité, Secrétariat d'Etat à la Santé et à l'Action Sociale. Maîtrise de la diffusion des bactéries multirésistantes aux antibiotiques. Paris: Ministère de l'emploi et de la solidarité. France, 1999
2. Wertheim HFL, Vos MC, Boelens HAM, et al. Low prevalence of methicillin-resistant Staphylococcus aureus at hospital admission in the Netherlands: the value of search and destroy and restrictive antibiotic use. J Hosp Infect 2004;56:321-325
3. Brun Y, Bes M. Staphylococcus. In: Freney J, Renaud F, Hansen W, Bollet C (eds), Précis de Bactériologie Clinique. Paris: ESKA, 2000, pp 783-830
4. Communiqué 2004 du Comité de l'Antibiogramme de la Société Française Microbiologie, http://WWW.sfm.asso.fr
5. Anonymous, ONERBA (Observatoire National de l'Epidémiologie de la Résistance Bactérienne aux Antibiotiques). Rapport d'activité du conseil scientifique. Paris: ONERBA, 1998
6. Lucet JC, Chevret S, Durand-Zaleski I, et al. Prevalence and risk factors for carriage of methicillin-resistant Staphylococcus aureus at admission to the intensive care unit. Arch Intern Med 2003;163:181-188
7. Kluytmans JA, Mouton JW, Ijzerman EP, et al. Nasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgery. J Infect Dis 1995;171:216-219
8. Kalmeijer MD, van Nieuwland-Bollen PM, Bogaers-Hofman D, de Baere GA. Nasal carriage of Staphylococcus aureus is a major risk factor for surgical site infections in orthopaedic surgery. Infect Control Hosp Epidemiol 2000;21:319-323
9. Merrer J, Pisica-Donose G, Leneveu M, Pauthier F. Prevalence of methicillin-resistant Staphylococcus aureus nasal carriage among patient with femoral neck fractures: implication for antibiotic prophylaxis. Infect Control Hosp Epidemiol 2004;25:515-517
10. Leman R, Alvarado-Ramy F, Pocockb S, et al. Nasal carriage of methicillin-resistant Staphylococcus aureus in an American Indian population. Infect Control Hosp Epidemiol 2004;25:121-125
11. Cesur S, Cokca F. Nasal carriage of methicillin-resistant Staphylococcus aureus among hospital staff and outpatients. Infect Control Hosp Epidemiol 2004;25:169-171
12. Solgado CD, Farr BM, Calfee DP. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis 2003;36:131-139
13. Fukuda M, Tanaka H, Kajiwara Y, et al. High-risk populations for nasal carriage of methicillin-resistant Staphylococcus aureus. J Infect Chemother 2004;10:189-191
14. Conférence de consensus. Société Française d'Hygiène Hospitalière. Gestion pré-opératoire du risque infectieux. 5 mars 2004, Institut Pasteur Paris, http://WWW.sfhh.net
15. Perl TM, Cullen JJ, Wenzel RP, et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med 2002;346:1871-1877
16. Kalmeijer MD, Coertjens H, van Nieuwland-Bollen PM, et al. Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study. Clin Infect Dis 2002;35:353-358
17. Kluytmans JA, Mouton JW, VandenBergh MF, et al. Reduction of surgical-site infections in cardiothoracic surgery by elimination of nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol 1996;17:775-779
18. Cimochowski GE, Harostock MD, Brown R, et al. Intranasal mupirocin reduces sternal wound infection after open heart surgery in diabetics and nondiabetics. Ann Thorac Surg 2001;71:1572-1578
19. Gernaat-van der Sluis AJ, Hoogenboom-Verdegaal AM, Edixhoven PJ, Spies-van Rooijen NH. Prophylactic mupirocin could reduce orthopedic wound infections. 1,044 patients treated with mupirocin compared with 1,260 historical controls. Acta Orthop Scand 1998;69:412-414
20. Conférence de consensus de la Société Française d'Anesthésie et de Réanimation. Antibioprophylaxie de l'adulte en milieu chirurgical. Mars 1999, http://WWW.sfar.org/